보고서 요약(국문)

보고서 개요
전 세계 장기 이식용 바이오프린팅 시장은 2023년 10억 5천만 달러에 달했으며, 2024년부터 2031년까지 연평균 13.2%의 성장률을 기록하며 2031년에는 27억 3천만 달러에 이를 것으로 예상됩니다.
체외에서 장기/조직을 생체 제조하는 기술은 장기 이식과 정확한 조직 모델이라는 두 가지 요구에 의해 주도되어 왔습니다. 3차원(3D) 프린팅이라고도 불리는 바이오프린팅은 간, 피부, 심장 등 다양한 조직/장기를 개발하는 데 사용되는 기술입니다. 이 기술은 생체 재료, 생존 가능한 세포 및 생체 분자를 사용하여 구조물을 프린팅하는 것과 관련이 있습니다. 생체 인공 장기의 개발은 미래 장기 이식 프로그램에 새로운 가능성을 열어주었습니다.
전 세계적으로 장기 이식 수요가 급증하고 있습니다. 주요 장기 부전 발생률 증가와 이식 후 성공률 향상으로 인해 장기 이식이 필요해졌습니다. 전 세계적으로 장기 이식 수요 증가와 공급 부족으로 심각한 장기 부족 사태가 발생하고 있습니다. 3D 바이오프린팅은 세포 또는 기타 생체 재료를 프린팅 잉크로 사용하여 적층 제조 방식을 통해 생체 모방 형태, 생체 기능 및 세포 미세 환경의 요구 사항에 따라 복잡한 3D 생체 구조를 생체 기능을 갖춘 형태로 제작하는 기술입니다.
시장 동향: 주요 동인
장기 이식 수요 증가
전 세계 장기 이식용 바이오프린팅 시장 수요는 여러 요인에 의해 주도되고 있습니다. 인공 장기 및 장기 이식 수요 증가가 시장 성장을 견인하고 있습니다.
또한, 기술 개발과 연구 자금 지원 확대가 전 세계 장기 이식용 바이오프린팅 시장 수요 증가를 촉진할 것으로 예상됩니다. 예를 들어, transplant.hrsa.gov에 따르면 2023년에는 생체 기증자와 사후 기증자를 합쳐 총 46,632건의 장기 이식이 시행되었습니다. 이는 2022년 대비 8.7%, 4만 건 이상의 장기 이식이 처음으로 시행된 2021년 대비 12.7% 증가한 수치입니다. 사후 기증자로부터의 장기 이식은 39,679건으로, 2022년 대비 8.9% 증가했으며 11년 연속 최고 기록을 경신했습니다.
예를 들어, 2024년 2월 nih.gov에 게시된 기사에 따르면 인도는 매년 17,000~18,000건의 고형 장기 이식을 시행하고 있으며, 이는 미국과 중국에 이어 세계에서 세 번째로 많은 수치이지만, 인구 100만 명당 이식률(0.65)은 여러 고소득 국가에 비해 여전히 낮은 수준입니다. 사망 기증자로부터 장기를 적출하는 기술이 향상되는 등 이 분야에서 진전이 있었으며, 기증자 1인당 평균 장기 이식 건수는 2016년 2.43건에서 2022년 3.05건으로 증가했습니다.
제약 요인
장기 이식과 관련된 부작용 및 위험, 인공 장기의 높은 비용, 숙련된 전문가 부족, 새로운 기술 승인을 위한 엄격한 규제 요건 등이 시장 성장을 저해할 것으로 예상됩니다.
시장 세분화 분석
전 세계 장기 이식용 바이오프린팅 시장은 공정, 바이오잉크, 사용되는 세포 유형, 최종 사용자 및 지역별로 세분화됩니다.
압출 기반 바이오프린팅 부문은 전 세계 장기 이식용 바이오프린팅 시장 점유율의 약 47.8%를 차지했습니다.
압출 기반 바이오프린팅 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이 부문에서는 정부 규제 개발과 민간 제조업체의 연구 개발 자금 증가가 시장 성장을 견인할 것입니다.

압출 기반 바이오프린팅은 장기 제작에 있어 독보적인 가능성을 제공하는 강력한 3차원(3D) 바이오프린팅 기술입니다. 이 기술은 지난 10년간 빠르게 성장해 왔습니다. 압출 기반 바이오프린팅은 세포, 조직, 오가노이드, 미세유체 장치 등 다양한 생물학적 화합물이나 장치를 프린팅하는 데 뛰어난 활용성을 제공하며, 이러한 프린팅 결과물은 기초 연구, 제약, 약물 테스트, 이식 및 임상 분야에 적용될 수 있습니다. 압출 기반 바이오프린팅은 조직 스페로이드, 세포 펠렛, 마이크로캐리어, 탈세포화된 기질 구성 요소, 세포 함유 하이드로겔 등 다양한 바이오잉크를 프린팅하는 데 탁월한 유연성을 제공합니다.
예를 들어, 2022년 4월 핀란드에 본사를 둔 바이오프린팅 스타트업 브린터(Brinter)는 자사 바이오프린터용 새로운 압출 기반 비스코 바이오(Visco Bio) 의료용 프린트헤드를 출시한다고 발표했습니다. 혁신적인 기술을 시장에 제공하는 퓨어다인(Puredyne)과의 긴밀한 협력을 통해 도입된 이 새로운 모듈형 프린트헤드는 고가의 의료용 재료 낭비를 최소화할 수 있도록 합니다.

시장 지역별 점유율
북미는 전 세계 장기 이식용 바이오프린팅 시장에서 약 42.5%의 점유율을 차지했습니다.
북미 지역은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 이 지역의 장기 이식 수요 증가와 기술 발전이 시장 성장을 견인하고 있습니다.
예를 들어, hrsa.gov에 발표된 기사에 따르면, 2024년 1월에는 16,000명 이상의 사망 기증자가 발생하여 연간 최고 기록을 경신했으며, 13년 연속 최고 기록 경신 추세를 이어갔습니다. 46,000건 이상의 장기 이식이 시행되어 연간 최고 기록을 경신하는 추세를 보였습니다. 이식 수혜자 중 10,000명 이상이 흑인 비히스패닉계였습니다. 10,000건 이상의 간 이식이 처음으로 시행되었고, 3,000건 이상의 폐 이식이 처음으로 시행되었습니다. 신장 및 심장 이식에서도 새로운 연간 기록이 세워졌습니다.

예를 들어, 2023년 11월 셀링크(Cellink)와 오시폼(Ossiform)은 오시폼의 기존 생체 재료를 기반으로 한 즉시 인쇄 가능한 바이오잉크를 상용화하기 위해 전략적 파트너십을 체결했습니다. 해당 재료의 판매는 2024년부터 시작되며 셀링크의 상업 채널을 통해 공동 독점적으로 유통될 예정입니다. 셀링크와 오시폼은 시너지를 활용하여 뼈 관련 연구에 적합한 고기능성 바이오잉크를 시장에 출시할 계획입니다. 이 파트너십은 임상 등급 바이오잉크를 포함한 추가적인 재료 개발 가능성도 열어두고 있습니다.
시장 세분화
공정별
• 잉크젯 바이오프린팅
• 레이저 보조 바이오프린팅
• 압출 기반 바이오프린팅
• 음향 바이오프린팅
• 자기 바이오프린팅
• 광중합 기반 바이오프린팅
• 기타
바이오잉크별
• PEG 디아크릴레이트
• 나노셀룰로오스
• 콜라겐 I
• 그래핀
• 기타
사용 세포 유형별
• 유도만능줄기세포(iPS 세포)
• 중간엽줄기세포
• 각질세포
• 신경줄기세포
• 기타
최종 사용자별
• 병원
• 연구 및 교육 기관
• 전문 클리닉
• 장기 이식 센터
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양 • 중국
• 인도
• 일본
• 한국
• 기타 아시아 태평양 지역
• 중동 및 아프리카
시장 경쟁 구도
장기 이식용 바이오프린팅 시장의 주요 글로벌 기업으로는 3D Systems Corporation, Protolabs, Materialise, Stratasys, General Electric Company, Desktop Metal Inc., Aspect Biosystems Ltd., EnvisionTEC Llc., Ibio Inc., Printivo 등이 있습니다.
주요 개발 사항
• 2022년 9월, 3D Systems는 첨단 바이오프린팅 기술을 제약 신약 개발에 적용하는 데 주력하는 생명공학 회사인 Systemic Bio™를 완전 자회사로 설립했다고 발표했습니다. Systemic Bio는 3D Systems의 획기적인 양산형 바이오프린팅 기술을 활용하여 생체 재료와 인간 세포를 사용하여 매우 정밀한 혈관화된 장기 모델을 제작할 예정입니다.

• 2023년 10월, Carcinotech와 3D 바이오프린팅 기업 CELLINK는 3D 바이오프린팅 종양 모델을 활용하여 암 치료제 개발을 가속화하기 위한 파트너십을 발표했습니다. 이번 파트너십은 암세포주를 이용한 3D 바이오프린팅 종양 모델의 생체 제작을 위한 최첨단 프로토콜 개발 및 상용화에 중점을 둘 것입니다. 이러한 모델은 신약 개발 과정의 정확도를 크게 향상시키고 속도를 높여 궁극적으로 개발 비용을 절감하고 연구 성과를 증대시키도록 설계되었습니다. 해당 프로토콜은 CELLINK의 최첨단 BIO CELLX 시스템에서 사용할 수 있도록 제공될 예정입니다.
• 2022년 6월, 조직 재생 및 장기 제조를 위한 혁신적인 기술과 제품을 개발하는 재생 및 미용 의학 기업인 CollPlant는 28억 달러 규모의 세계 유방 보형물 시장을 겨냥하여 3D 바이오프린팅 재생 유방 보형물 프로그램에 대한 대형 동물 연구 착수를 발표했습니다.

보고서 구매 이유:
이 보고서는 공정, 바이오잉크, 사용된 세포 유형, 최종 사용자 및 지역별로 세분화된 전 세계 장기 이식용 바이오프린팅 시장을 시각화하고 주요 상업 자산 및 기업을 파악하는 데 도움을 줍니다.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.
• 모든 세그먼트를 포함한 글로벌 장기 이식 바이오프린팅 시장의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 장기 이식 바이오프린팅 시장 보고서는 약 51개의 표, 54개의 그림, 그리고 181페이지 분량으로 구성됩니다.
주요 고객 (2024년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Report Overview
The Global Bioprinting on Organ Transplant Market reached US$ 1.05 billion in 2023 and is expected to reach US$ 2.73 billion by 2031, growing at a CAGR of 13.2% during the forecast period 2024-2031.
Biomanufacturing of organs/tissues in vitro has been driven by two needs, i.e., organ transplantation and accurate tissue models. Bioprinting, also known as three-dimensional (3D) printing, is a technique used to develop many tissues/organs, such as the liver, skin, and heart. This technique is associated with printing structures using biomaterials, viable cells, and biomolecules. The creation of bioartificial organs has opened new avenues for future organ transplantation programs.
The demand for organ transplants has increased rapidly worldwide. Organ transplants are required due to the increased incidence of vital organ failure and the higher success rate of post-transplant outcomes. Globally, a major organ shortage crisis has emerged due to higher demand and insufficient supply of organs for transplant. 3D bioprinting uses cells or other bio-materials as printing inks to print complex 3D biological structures with biological functions according to the requirements of the bionic morphology, biological function, and cellular microenvironment through additive manufacturing methods.
Market Dynamics: Drivers
Increasing need for organ transplantation
The demand for global bioprinting on organ transplantation market is driven by multiple factors. The increase in the need for artificial organs and organ transplantation propels the market growth.
Furthermore, the demand for global bioprinting on organ transplantation market will be fueled by technological developments and funding allotted for research work. For instance, according to transplant.hrsa.gov, There were 46,632 organ transplants performed from both living and deceased donors in 2023. This represents an 8.7 percent increase over 2022 and a 12.7 percent increase over 2021, which was the first year with more than 40,000 organ transplants. There were 39,679 organ transplants from deceased donors. This represents an 8.9 percent increase over 2022 and marks the eleventh consecutive record-setting year.
For instance, according to an article posted by nih.gov in February 2024, India sees 17,000–18,000 solid organ transplants performed every year, the most in the world after the US and China, but remains behind several high-income countries in transplantation rates per million population (0.65). There has been progress in this area, such as an improvement in the harvesting of organs from deceased donors, with the average number of organ transplants per donor increasing from 2.43 in 2016 to 3.05 in 2022.
Restraints
Factors such as side effects and risks related to organ transplantation, the high cost of artificial organs, the shortage of skilled professionals, and stringent regulatory requirements for the approval of new techniques are expected to hamper the market.
Market Segment Analysis
The global bioprinting on organ transplantation market is segmented based on process, bioink, cell type used, end-user, and region.
The segment extrusion-based bioprinting accounted for approximately 47.8% of the global bioprinting on organ transplantation market share
The extrusion-based bioprinting segment is expected to hold the largest market share over the forecast period. In this segment, the development of government regulation, and rising funds for private manufacturers for research work would drive this market.
Extrusion-based bioprinting is a powerful three-dimensional (3D) bioprinting technology that provides unique opportunities for use in organ fabrication. This technology has grown rapidly during the last decade. Extrusion-based bioprinting provides great versatility in printing various biological compounds or devices, including cells, tissues, organoids, and microfluidic devices that can be applied in basic research, pharmaceutics, drug testing, transplantation, and clinical uses. Extrusion-based bioprinting offers great flexibility in printing a wide range of bioinks, including tissue spheroids, cell pellets, microcarriers, decellularized matrix components, and cell-laden hydrogels.
For instance, in April 2022, Finland-based bioprinting startup Brinter announced the launch of a new extrusion-based Visco Bio medical printhead for its bioprinters. New modular printheads introduced in close collaboration with Puredyne, who provides innovative technologies to the market, allow waste of expensive medical grade materials to be kept to a minimum.
Market Geographical Share
North America accounted for approximately 42.5% of the global bioprinting on organ transplantation market share
North America region is expected to hold the largest market share over the forecast period. The increasing demand for organ transplantation, and technological advancements, in this region, help to propel the market.
For instance, according to an article published by hrsa.gov, in January 2024, More than 16,000 deceased organ donors, a new annual record and a continuation of a 13-year annual record trend. More than 46,000 organ transplants were performed, continuing an annual record-setting trend. More than 10,000 transplant recipients were Black, and non-Hispanic. More than 10,000 liver transplants were performed for the first time. More than 3,000 lung transplants were performed for the first time. New annual records are also set for kidney and heart transplants.
For instance, in November 2023, Cellink and Ossiform entered a strategic partnership to join forces to commercialize a ready-to-print bioink based on Ossiform’s existing biomaterial. Sales of the material will begin in 2024 and will be distributed co-exclusively through Cellink’s commercial channels. Cellink and Ossiform are planning to capitalize on synergies and bring to the market a highly functional bio-ink for bone-based research. The partnership has scope for additional materials, including clinical-grade bioinks.
Market Segmentation
By Process
• Inkjet Bioprinting
• Laser-Assisted Bioprinting
• Extrusion-Based Bioprinting
• Acoustic Bioprinting
• Magnetic Bioprinting
• Vatphotopolymerization-based bioprinting
• Others
By Bioink
• PEG diacrylate
• Nanocellulose
• Collagen I
• Graphene
• Others
By Cell Type Used
• iPS Cells
• Mesenchymal Stem Cells
• Keratinocytes
• Neural Stem Cell
• Others
By End-User
• Hospitals
• Research and Educational Institutions
• Specialty Clinics
• Organ Transplantation Centers
• Others
By Region
• North America
o The U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Market Competitive Landscape
The major global players in the global bioprinting on organ transplantation market include 3D Systems Corporation, Protolabs, Materialise, Stratasys, General Electric Company, Desktop Metal Inc., Aspect Biosystems Ltd., EnvisionTEC Llc., Ibio Inc., and Printivo among others.
Key Developments
• In September 2022, 3D Systems announced the formation of a new, wholly-owned company called Systemic Bio™, a biotech company focused on the application of advanced bioprinting technologies to pharmaceutical drug discovery and development. Systemic Bio will leverage 3D Systems’ breakthrough, production-level bioprinting technology to create extremely precise vascularized organ models using biomaterials and human cells.
• In October 2023, Carcinotech and 3D bioprinting firm CELLINK announced a partnership to accelerate cancer drug development with 3D bio-printed tumor models. The partnership will focus on the development and commercialization of cutting-edge protocols for the biofabrication of 3D bio-printed tumor models using cancer cell lines. These models are designed to significantly improve accuracy and speed up drug development processes, ultimately reducing development costs and enhancing research output. The protocols will be made available for use on CELLINK’s state-of-the-art BIO CELLX system.
• In June 2022, CollPlant a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced the initiation of a study in large animals for its 3D bioprinted regenerative breast implant program, addressing the $2.8 billion global breast implant market.
Why Purchase the Report?
To visualize the global bioprinting on organ transplantation market segmentation based on, process, bioink, cell type used, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of global bioprinting on organ transplantation market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.
The global bioprinting on organ transplantation market report would provide approximately 51 tables, 54 figures, and 181 Pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Process
3.2. Snippet by Bioink
3.3. Snippet by Cell Type Used
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Need for Organ Transplantation
4.1.1.2. Technological Advancements
4.1.1.3. Hefty Funds Allotted for the Research Work
4.1.2. Restraints
4.1.2.1. High Cost of Artificial Organs
4.1.2.2. Shortage of Skilled Professionals
4.1.2.3. Stringent Regulatory Requirements
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. By Process
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
6.1.2. Market Attractiveness Index, By Process
6.2. Inkjet Bioprinting*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Laser-Assisted Bioprinting
6.4. Extrusion-Based Bioprinting
6.5. Acoustic Bioprinting
6.6. Magnetic Bioprinting
6.7. Vatphotopolymerization-based Bioprinting
6.8. Others
7. By Bioink
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
7.1.2. Market Attractiveness Index, By Bioink
7.2. PEG Diacrylate*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Nanocellulose
7.4. Collagen I
7.5. Graphene
7.6. Others
8. By Cell Type Used
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
8.1.2. Market Attractiveness Index, By Cell Type Used
8.2. iPS Cells*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Mesenchymal Stem Cells
8.4. Keratinocytes
8.5. Neural Stem Cells
8.6. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Research and Educational Institutions
9.4. Speciality Clinics
9.5. Organ Transplantation Centers
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bioink
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type Used
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. 3D Systems Corporation *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Cell Ink
12.3. Materialise
12.4. Stratasys
12.5. General Electric Company
12.6. Desktop Metal Inc.
12.7. Aspect Biosystems Ltd.
12.8. EnvisionTEC Llc.
12.9. Ibio Inc.
12.10. Printivo (*LIST NOT EXHAUSTIVE)
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

3D Systems Corporation, 4.	Key Developments, Cell Ink, Materialise, Stratasys, General Electric Company, Desktop Metal Inc., Aspect Biosystems Ltd., EnvisionTEC Llc., Ibio Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Bioprinting on Organ Transplant Market Value, By Process, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Bioprinting on Organ Transplant Market Value, By Bioink, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Bioprinting on Organ Transplant Market Value, By Cell Type Used, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Bioprinting on Organ Transplant Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Bioprinting on Organ Transplant Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Bioprinting on Organ Transplant Market Value, By Process, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Bioprinting on Organ Transplant Market Value, By Process, 2022-2031 (US$ Million)

Table 8 Global Bioprinting on Organ Transplant Market Value, By Bioink, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Bioprinting on Organ Transplant Market Value, By Bioink, 2022-2031 (US$ Million)

Table 10 Global Bioprinting on Organ Transplant Market Value, By Cell Type Used, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Bioprinting on Organ Transplant Market Value, By Cell Type Used, 2022-2031 (US$ Million)

Table 12 Global Bioprinting on Organ Transplant Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Bioprinting on Organ Transplant Market Value, By End-User, 2022-2031 (US$ Million)

Table 14 Global Bioprinting on Organ Transplant Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Bioprinting on Organ Transplant Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Bioprinting on Organ Transplant Market Value, By Process, 2022-2031 (US$ Million)

Table 17 North America Bioprinting on Organ Transplant Market Value, By Bioink, 2022-2031 (US$ Million)

Table 18 North America Bioprinting on Organ Transplant Market Value, By Cell Type Used, 2022-2031 (US$ Million)

Table 19 North America Bioprinting on Organ Transplant Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 North America Bioprinting on Organ Transplant Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Bioprinting on Organ Transplant Market Value, By Process, 2022-2031 (US$ Million)

Table 22 South America Bioprinting on Organ Transplant Market Value, By Bioink, 2022-2031 (US$ Million)

Table 23 South America Bioprinting on Organ Transplant Market Value, By Cell Type Used, 2022-2031 (US$ Million)

Table 24 South America Bioprinting on Organ Transplant Market Value, By End-User, 2022-2031 (US$ Million)

Table 25 South America Bioprinting on Organ Transplant Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Bioprinting on Organ Transplant Market Value, By Process, 2022-2031 (US$ Million)

Table 27 Europe Bioprinting on Organ Transplant Market Value, By Bioink, 2022-2031 (US$ Million)

Table 28 Europe Bioprinting on Organ Transplant Market Value, By Cell Type Used, 2022-2031 (US$ Million)

Table 29 Europe Bioprinting on Organ Transplant Market Value, By End-User, 2022-2031 (US$ Million)

Table 30 Europe Bioprinting on Organ Transplant Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Bioprinting on Organ Transplant Market Value, By Process, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Bioprinting on Organ Transplant Market Value, By Bioink, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Bioprinting on Organ Transplant Market Value, By Cell Type Used, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Bioprinting on Organ Transplant Market Value, By End-User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Bioprinting on Organ Transplant Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East and Africa Bioprinting on Organ Transplant Market Value, By Process, 2022-2031 (US$ Million)

Table 37 Middle East and Africa Bioprinting on Organ Transplant Market Value, By Bioink, 2022-2031 (US$ Million)

Table 38 Middle East and Africa Bioprinting on Organ Transplant Market Value, By Cell Type Used, 2022-2031 (US$ Million)

Table 39 Middle East and Africa Bioprinting on Organ Transplant Market Value, By End-User, 2022-2031 (US$ Million)

Table 40 Middle East and Africa Bioprinting on Organ Transplant Market Value, By Country, 2022-2031 (US$ Million)

Table 41 3D Systems Corporation: Overview

Table 42 3D Systems Corporation: Product Portfolio

Table 43 3D Systems Corporation: Key Developments

Table 44 Protolabs: Overview

Table 45 Protolabs: Product Portfolio

Table 46 Protolabs: Key Developments

Table 47 Materialise: Overview

Table 48 Materialise: Product Portfolio

Table 49 Materialise: Key Developments

Table 50 Stratasys: Overview

Table 51 Stratasys: Product Portfolio

Table 52 Stratasys: Key Developments

Table 53 General Electric Company: Overview

Table 54 General Electric Company: Product Portfolio

Table 55 General Electric Company: Key Developments

Table 56 Desktop Metal Inc.: Overview

Table 57 Desktop Metal Inc.: Product Portfolio

Table 58 Desktop Metal Inc.: Key Developments

Table 59 Aspect Biosystems Ltd.: Overview

Table 60 Aspect Biosystems Ltd.: Product Portfolio

Table 61 Aspect Biosystems Ltd.: Key Developments

Table 62 EnvisionTEC Llc.: Overview

Table 63 EnvisionTEC Llc.: Product Portfolio

Table 64 EnvisionTEC Llc.: Key Developments

Table 65 Ibio Inc.: Overview

Table 66 Ibio Inc.: Product Portfolio

Table 67 Ibio Inc.: Key Developments

Table 68 Printivo: Overview

Table 69 Printivo: Product Portfolio

Table 70 Printivo: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 2 Global Bioprinting on Organ Transplant Market Share, By Process, 2023 & 2031 (%)

Figure 3 Global Bioprinting on Organ Transplant Market Share, By Bioink, 2023 & 2031 (%)

Figure 4 Global Bioprinting on Organ Transplant Market Share, By Cell Type Used, 2023 & 2031 (%)

Figure 5 Global Bioprinting on Organ Transplant Market Share, By End-User, 2023 & 2031 (%)

Figure 6 Global Bioprinting on Organ Transplant Market Share, By Region, 2023 & 2031 (%)

Figure 7 Global Bioprinting on Organ Transplant Market Y-o-Y Growth, By Process, 2023-2031 (%)

Figure 8 Inkjet Bioprinting Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 9 Laser-Assisted Bioprinting Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 10 Extrusion-Based Bioprinting Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 11 Acoustic Bioprinting Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 12 Magnetic Bioprinting Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 13 Vatphotopolymerization-based bioprinting Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 14 Others Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 15 Global Bioprinting on Organ Transplant Market Y-o-Y Growth, By Bioink, 2023-2031 (%)

Figure 16 PEG diacrylate Bioink in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 17 Nanocellulose Bioink in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 18 Collagen I Bioink in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 19 Graphene Bioink in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 20 Others Bioink in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 21 Global Bioprinting on Organ Transplant Market Y-o-Y Growth, By Cell Type Used, 2023-2031 (%)

Figure 22 iPS Cells Cell Type Used in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 23 Mesenchymal Stem Cells Cell Type Used in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 24 Keratinocytes Cell Type Used in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 25 Neural Stem Cell Cell Type Used in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 26 Others Cell Type Used in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 27 Global Bioprinting on Organ Transplant Market Y-o-Y Growth, By End-User, 2023-2031 (%)

Figure 28 Hospitals End-User in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 29 Research and Educational Institutions End-User in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 30 Specialty Clinics End-User in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 31 Organ Transplantation Centers End-User in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 32 Others End-User in Global Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 33 Global Bioprinting on Organ Transplant Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 34 North America Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 35 North America Bioprinting on Organ Transplant Market Share, By Process, 2023 & 2031 (%)

Figure 36 North America Bioprinting on Organ Transplant Market Share, By Bioink, 2023 & 2031 (%)

Figure 37 North America Bioprinting on Organ Transplant Market Share, By Cell Type Used, 2023 & 2031 (%)

Figure 38 North America Bioprinting on Organ Transplant Market Share, By End-User, 2023 & 2031 (%)

Figure 39 North America Bioprinting on Organ Transplant Market Share, By Country, 2023 & 2031 (%)

Figure 40 South America Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 41 South America Bioprinting on Organ Transplant Market Share, By Process, 2023 & 2031 (%)

Figure 42 South America Bioprinting on Organ Transplant Market Share, By Bioink, 2023 & 2031 (%)

Figure 43 South America Bioprinting on Organ Transplant Market Share, By Cell Type Used, 2023 & 2031 (%)

Figure 44 South America Bioprinting on Organ Transplant Market Share, By End-User, 2023 & 2031 (%)

Figure 45 South America Bioprinting on Organ Transplant Market Share, By Country, 2023 & 2031 (%)

Figure 46 Europe Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 47 Europe Bioprinting on Organ Transplant Market Share, By Process, 2023 & 2031 (%)

Figure 48 Europe Bioprinting on Organ Transplant Market Share, By Bioink, 2023 & 2031 (%)

Figure 49 Europe Bioprinting on Organ Transplant Market Share, By Cell Type Used, 2023 & 2031 (%)

Figure 50 Europe Bioprinting on Organ Transplant Market Share, By End-User, 2023 & 2031 (%)

Figure 51 Europe Bioprinting on Organ Transplant Market Share, By Country, 2023 & 2031 (%)

Figure 52 Asia-Pacific Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 53 Asia-Pacific Bioprinting on Organ Transplant Market Share, By Process, 2023 & 2031 (%)

Figure 54 Asia-Pacific Bioprinting on Organ Transplant Market Share, By Bioink, 2023 & 2031 (%)

Figure 55 Asia-Pacific Bioprinting on Organ Transplant Market Share, By Cell Type Used, 2023 & 2031 (%)

Figure 56 Asia-Pacific Bioprinting on Organ Transplant Market Share, By End-User, 2023 & 2031 (%)

Figure 57 Asia-Pacific Bioprinting on Organ Transplant Market Share, By Country, 2023 & 2031 (%)

Figure 58 Middle East and Africa Bioprinting on Organ Transplant Market Value, 2022-2031 (US$ Million)

Figure 59 Middle East and Africa Bioprinting on Organ Transplant Market Share, By Process, 2023 & 2031 (%)

Figure 60 Middle East and Africa Bioprinting on Organ Transplant Market Share, By Bioink, 2023 & 2031 (%)

Figure 61 Middle East and Africa Bioprinting on Organ Transplant Market Share, By Cell Type Used, 2023 & 2031 (%)

Figure 62 Middle East and Africa Bioprinting on Organ Transplant Market Share, By End-User, 2023 & 2031 (%)

Figure 63 3D Systems Corporation: Financials

Figure 64 Protolabs: Financials

Figure 65 Materialise: Financials

Figure 66 Stratasys: Financials

Figure 67 General Electric Company: Financials

Figure 68 Desktop Metal Inc.: Financials

Figure 69 Aspect Biosystems Ltd.: Financials

Figure 70 EnvisionTEC Llc.: Financials

Figure 71 Ibio Inc.: Financials

Figure 72 Printivo: Financials

장기 이식 분야 글로벌 바이오프린팅 시장 – 2024-2031년

Global Bioprinting on Organ Transplant Market - 2024-2031